abrdn Asia Limited reduces stake in Vijaya Diagnostic Centre
abrdn Asia Limited reduced its stake in Vijaya Diagnostic Centre Limited by selling 133,199 shares on June 29, 2026. The open market sale lowered the acquirer's holding to 3.2373%, or 3,331,046 shares. The transaction was disclosed under SEBI takeover regulations.

*this image is generated using AI for illustrative purposes only.
abrdn Asia Limited, acting on behalf of funds advised and managed by the group, reduced its shareholding in Vijaya Diagnostic Centre Limited through an open market sale on June 29, 2026. The transaction involved the disposal of 133,199 equity shares, resulting in a decrease of the acquirer's voting rights by 0.1294%. This regulatory filing was submitted under Regulation 29(2) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
Prior to the sale, the acquirer held 3,464,245 shares, representing 3.3667% of the total share capital. The shares were held across various funds within the Aberdeen Group, including the Aberdeen Group plc Segregated Fund, Aberdeen India Fund, Inc., and Aberdeen Asia Focus plc. Registered holders for these securities included entities such as Pictet & Cie - Switzerland, State Street Bank & Trust, and BNP Paribas Securities Services.
The disposal was executed entirely through the open market mode. As a result of the transaction, the total holding of abrdn Asia Limited and its Persons Acting in Concert (PAC) now stands at 3,331,046 shares. This revised holding constitutes 3.2373% of the total voting capital of Vijaya Diagnostic Centre Limited. The equity share capital of the company remains unchanged at Rs. 102,896,728, based on a par value of Rs 1.
The filing confirms that the acquirer does not belong to the promoter or promoter group of the target company. The shares of Vijaya Diagnostic Centre Limited are listed on BSE Limited and the National Stock Exchange of India Ltd. The disclosure was signed by Jenny Clarke, an authorised signatory for abrdn Asia Limited, in Edinburgh on June 30, 2026.
Shareholding Details
The following table outlines the changes in the acquirer's shareholding:
| Description | Number of Shares | % of Total Share Capital | % of Diluted Share Capital |
|---|---|---|---|
| Holding Before Sale | |||
| Shares carrying voting rights | 3,464,245 | 3.3667 | 3.3667 |
| Transaction Details | |||
| Shares sold | -133,199 | -0.1294 | -0.1294 |
| Holding After Sale | |||
| Shares carrying voting rights | 3,331,046 | 3.2373 | 3.2373 |
Historical Stock Returns for Vijaya Diagnostic Centre
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -2.33% | -0.19% | +3.66% | +28.89% | +39.33% | +120.16% |
Does this sale signal a broader shift in abrdn’s investment strategy regarding the Indian healthcare sector?
How might this reduction in institutional holding impact the liquidity and trading volume of Vijaya Diagnostic Centre shares?
Is abrdn planning to further decrease its stake in the company in the upcoming quarters?































